10-Q
Quarterly Report
AIM IMMUNOTECH INC.
AIM
NYSEAMER
CIK: 946644
File #: 001-27072
Balance Sheet
40 line items · 2 periods
XBRL
| Item | Mar 31, 2026 | Dec 31, 2025 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 5,816,000 | 2,985,000 |
Marketable securities | 63,000 | 62,000 |
Fair Value, Recurring | 63,000 | 62,000 |
Fair Value, Inputs, Level 1 - Fair Value, Recurring | 63,000 | 62,000 |
Accounts Receivable | — | 7,000 |
Other Non-Operating Current Assets | 335,000 | 241,000 |
Total current assets | 6,214,000 | 3,295,000 |
Property, Plant and Equipment | 62,000 | 71,000 |
Operating Lease Right-of-Use Asset | 320,000 | 378,000 |
Intangible Assets | 1,662,000 | 1,661,000 |
Patents | 1,603,000 | 1,599,000 |
Trademarks | 59,000 | 62,000 |
Other Non-Operating Non-Current Assets | 327,000 | 377,000 |
Total assets | 8,585,000 | 5,782,000 |
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||
Current liabilities: | ||
Accounts Payable | 1,215,000 | 1,630,000 |
Other Current Liabilities | 671,000 | 795,000 |
Operating Lease Liability, Current | 255,000 | 250,000 |
Short-Term Debt | 4,004,000 | 3,549,000 |
Total current liabilities | 6,145,000 | 6,224,000 |
Long-term liabilities: | ||
Operating Lease Liability, Non-Current | 105,000 | 170,000 |
Long-Term Debt | 210,000 | 927,000 |
Other Non-Operating Non-Current Liabilities | — | 8,244,000 |
Fair Value, Recurring | — | 8,244,000 |
Total liabilities | 6,460,000 | 15,565,000 |
Stockholders’ equity (deficit): | ||
Total Stockholders' Equity | 8,000 | 3,000 |
Total Stockholders' Equity | 445,926,000 | 431,000,000 |
Total Stockholders' Equity | (443,809,000) | (440,786,000) |
Total stockholders’ equity (deficit) | 2,125,000 | (9,783,000) |
Series G Preferred Stock - Preferred Stock | 678,000 | — |
Common Stock | 8,000 | 3,000 |
Additional Paid-in Capital | 445,926,000 | 431,000,000 |
Retained Earnings | (443,809,000) | (440,786,000) |
Minimum | 6,000,000 | — |
Total liabilities and stockholders’ equity (deficit) | 8,585,000 | 5,782,000 |